Postoperative nausea and vomiting. Anaesthetic, unspecified
Conditions
Interventions
Intervention 1: Group MO (n = 44) that received intravenous midazoalm 30 µg/kg combined with intravenous ondansetron 8 mg. Intervention 2: Group O (n = 44) which received intravenous ondansetron 8 mg
. Intervention 3: Group M (n = 44) received intravenous midazoalm 30 µg/kg.
Treatment - Drugs
Group MO (n = 44) that received intravenous midazoalm 30 µg/kg combined with intravenous ondansetron 8 mg
Group O (n = 44) which received intravenous ondansetron 8 mg
Group M (n = 44) received intravenous midazoalm 30 µg/kg.
Sponsors
Isfahan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients with ASA I; age between 18 to 45 years old; scheduled for elective cesarean delivery under spinal anesthesia and signing written informed consent to participate in the present study. Exclusion criteria: patients who had smoking habit; obstetric complications or any evidence of fetal compromise; patients who had history of motion sickness; previous postoperative emesis; gastrointestinal disease or administration of antiemetic medication in the previous 24 hours; having allergy to the study drugs and any contraindication for spinal anesthesia.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative nausea and vomiting. Timepoint: Half an hour afer Intevention. Method of measurement: Visual analogous scale(VAS). | — |
Secondary
| Measure | Time frame |
|---|---|
| Sedation. Timepoint: Half, 2,4 and 24 hours after intervention. Method of measurement: Ramsay sedation scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Mitra Jabalameli
Isfahan University of Medical Sciences
Outcome results
None listed